Clinical Report: COVID-19, Vaccines, and Retinal Vascular Disease

Overview

Revise to specify the statistical significance of retinal vein occlusion findings.

Background

Understanding the impact of COVID-19 on retinal health is crucial as it can lead to significant ocular complications. The associations between COVID-19 infection, vaccination, and retinal vascular diseases highlight the need for ongoing surveillance and clinical awareness among retina specialists. This topic is particularly relevant given the global vaccination efforts and the emergence of new variants.

Data Highlights

A systematic review of 173 studies involving 13.8 million people found:

• Retinal artery occlusion more common after COVID-19 infection.
• Retinal vein occlusion more common after COVID-19 vaccination.
• mRNA vaccines associated with higher ocular adverse events (0.0073 per million doses).
• Pooled relative risk for retinal vein occlusion was 2.4, but statistically inconclusive due to study heterogeneity.

Key Findings

• Retinal artery occlusion and optic neuritis were more prevalent following COVID-19 infection.
• Retinal vein occlusion was more frequently reported after COVID-19 vaccination.
• The mRNA vaccine platform showed a statistically significant association with ocular adverse events.
• Need for broader differential diagnoses including RVO and white dot syndrome in COVID-19 cases.
• Global vaccine surveillance is essential to monitor ocular complications.

Clinical Implications

Retina specialists should consider the potential for retinal vascular occlusions in patients with a history of COVID-19 infection or vaccination. Enhanced vigilance and reporting of ocular adverse events following vaccination are necessary to inform clinical practice and patient management.

Conclusion

The findings underscore the importance of understanding the ocular implications of COVID-19 and its vaccines, necessitating ongoing research and clinical vigilance in retinal health.

Related Resources & Content

1. Retinal Physician, Effects of COVID-19 Infection and Vaccination in the Retina, 2023 -- https://retinalphysician.com/issues/2023/october/effects-of-covid-19-infection-and-vaccination-in-the-retina/
2. Retinal Physician, SUBSPECIALTY NEWS: Gene therapy, new treatments, and coronavirus impact on retina practice, 2020 -- https://www.retinalphysician.com/issues/2020/june/subspecialty-news-gene-therapy-new-treatments-and-coronavirus-impact-on-retina-practice
3. Ophthalmology Management, Innovating our way to recovery, 2020 -- https://ophthalmologymanagement.com/issues/2020/july/innovating-our-way-to-recovery/
4. Management of Central Retinal Artery Occlusion A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association - Slide Set -- https://professional.heart.org/en/-/media/PHD-Files-2/Science-News/m/management_of_central_retinal_artery_occlusion_slide_set.pdf?sc_lang=en
5. Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis - PMC -- https://pmc.ncbi.nlm.nih.gov/articles/PMC9011173/?utm_source=openai
6. Macular and retinal manifestations following COVID-19 vaccinations: a 2025 update systematic review and meta-analysis | Eye -- https://www.nature.com/articles/s41433-026-04324-4?utm_source=openai
7. Retinal Physician — Clinical Trial Update June 2025
8. Management of Central Retinal Artery Occlusion A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association - Slide Set
9. Changes in the Incidence of Retinal Vascular Occlusions After COVID-19 Diagnosis - PMC
10. Macular and retinal manifestations following COVID-19 vaccinations: a 2025 update systematic review and meta-analysis | Eye